Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the [...]
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Many middle-income countries are left out of the deal, widening [...]
Gilead Shot Provides Total Protection From HIV in Trial of Young African Women
An injection given just twice a year could herald a [...]
U.S. Lags Behind Other Countries in Hepatitis-C Cures
Despite an arsenal of drugs, many Americans are still unaware [...]
Why One Drug Company Held Back a Better Drug
Drug companies say patents spur innovation. Can they also do [...]
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it [...]
Gilead Wins Key Patent Rights Suit Over HIV Prevention Drug PrEP
A jury sided with Gilead Sciences in a dispute over [...]
F.D.A. Approves Remdesivir for Patients Not Hospitalized
The treatment must be given via intravenous infusion over three [...]